JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jubilant Pharmova's Board has approved a final dividend of Rs. 5 per equity share (500% on face value of Re. 1) for FY 2026, subject to shareholder approval at the AGM. The record date for dividend eligibility is fixed as July 24, 2026. The company also reported audited consolidated results showing revenue from operations of Rs. 82,250 million for FY 2026, up from Rs. 71,921 million in FY 2025. Consolidated profit after tax stood at Rs. 5,464 million for FY 2026. The total dividend payout amounts to approximately Rs. 796 million. Auditors issued unmodified opinions on both standalone and consolidated financial statements.
The recommended dividend of Rs. 5 per share signals consistent shareholder returns. With no record date revision or other corporate actions like buyback or bonus, this is a straightforward dividend announcement that should support investor confidence in the company's cash generation.